Journal DOI 10.68956/journal.human-performance-futures

Creative Commons source reading · Return-to-sport readiness

Cardiac Arrest in a Young Soccer Player With a Pathogenic SCN5A Variant

Sigal IR; Power J; Kontorovich AR; Musikantow D

Originally published in JACC Case Rep · 2026-07-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

AbstractBackgroundThe SCN5A gene encodes the alpha subunit of the cardiac sodium channel; variants are associated with inherited cardiac diseases including long QT syndrome, sick sinus syndrome, dilated cardiomyopathy, arrhythmogenic cardiomyopathy, and Brugada syndrome.Case SummaryA 19-year-old male soccer player with a family history of sudden cardiac death collapsed during practice and received an automated external defibrillator shock for polymorphic ventricular tachycardia. Genetic testing identified a pathogenic SCN5A c.4222G>A (p.Gly1408Arg) variant previously associated with Brugada syndrome, although no Brugada pattern was identified on electrocardiogram. A subcutaneous implantable cardioverter-defibrillator was placed. After 8 months without arrhythmias and a reassuring exercise stress test, the patient returned to…

Discussion

The SCN5A gene encodes the alpha subunit of the cardiac sodium channel; SCN5A variants are associated with cardiac pathologies including Brugada syndrome, familial sick sinus syndrome, congenital long QT syndrome, dilated cardiomyopathy, and ACM. The c.4222G>A variant has been reported in patients with Brugada syndrome2 and familial sick sinus syndrome.3 Brugada syndrome is a Mendelian inherited sodium-channel disorder with an estimated prevalence of 1 in 5,000;4 despite the strong association with SCN5A, most patients with clinically diagnosed Brugada syndrome lack an identifiable genetic variant.4 Brugada syndrome is diagnosed by a characteristic type 1 Brugada pattern on ECG; when the initial ECG is negative, the Brugada pattern may be unmasked through provocative testing such as procainamide challenge. Although our patient did not…

Conclusions

Genetic evaluation is essential in young athletes with unexplained cardiac arrest, guiding management and enabling family screening. Return-to-sport decisions for patients with pathogenic SCN5A variants require individualized assessment and shared decision-making given the limited evidence base. This case also underscores the impact of rapid AED deployment and emergency action protocols in athletic environments.

Editorial reading guide

  • How were injury, recovery and exposure defined and verified?
  • Which criteria support progression, and what finding should stop or change the plan?